Medovex Overview

  • Founded
  • 2013

Founded
  • Status
  • Public

  • Employees
  • 8

Employees
  • Stock Symbol
  • HCYTD

Stock Symbol
  • Investments
  • 3

  • Share Price
  • $19.95

  • (As of Monday Closing)

Medovex General Information

Description

H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.

Contact Information

Website
www.hcyte.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PINX
Primary Office
  • 3060 Royal Boulevard South
  • Suite 150
  • Alpharetta, GA 30022
  • United States
+1 (404) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medovex Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.95 $19.95 $10.00 - $289.00 $5.09M 255K 59.24 -$34.12

Medovex Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 11,231 12,164 29 15,160
Revenue 1,615 1,612 2,151 8,347
EBITDA (7,033) (4,607) (4,915) (28,674)
Net Income (7,283) (4,799) (6,459) (29,808)
Total Assets 701 321 2,204 3,271
Total Debt 3,556 3,618 1,173 2,894
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medovex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medovex‘s full profile, request access.

Request a free trial

Medovex Patents

Medovex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3407810-A1 Surgical tools for spinal facet therapy to alleviate pain Pending 29-Jan-2016 000000000
US-10595919-B2 Surgical tools with positional components Active 12-Dec-2014 000000000 000
US-20180310975-A1 Surgical tools with positional components Granted 12-Dec-2014 00000000000 00
EP-3190997-B8 Surgical tools with positional components Active 12-Dec-2014 00000000000
EP-3190997-A4 Surgical tools with positional components Granted 12-Dec-2014 A61B17/8861 0
To view Medovex’s complete patent history, request access »

Medovex Executive Team (7)

Name Title Board Seat Contact Info
Robert Greif Chief Executive Officer & President
William Horne Chief Executive Officer & Chairman
Tanya Rhodes Chief Scientific Officer & Interim Chief Executive Officer
Charlie Farrahar Chief Financial Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Medovex Board Members (4)

Name Representing Role Since
0000000 000000000 Self Board Member 000 0000
0000000 0000000000 Medovex Board Member 000 0000
0000000 00000 Medovex Chief Executive Officer & Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Medovex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medovex Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medovex‘s full profile, request access.

Request a free trial

Medovex Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 11-Jan-2022 0000000000 Other Devices and Supplies 0000000 0
000000000000 14-Jan-2019 000000000 Buildings and Property 0000000 0
Streamline (Healthcare) 26-Mar-2015 Merger/Acquisition 00.00 Other Healthcare Technology Systems 0000000 0
To view Medovex’s complete investments and acquisitions history, request access »